Icon

CEDAX (nda050685)- (EQ 400MG BASE)

CEFTIBUTEN DIHYDRATE SI PHARMS
EQ 400MG BASE
No No
2013-Apr-30 Expired
None None
None No
CEDAX (ceftibuten) is indicated for the treatment of individuals with mild-to-moderate infections: Acute bacterial exacerbations of Chronic Bronchitis, Acute bacteria Otitis Media and Pharyngitis and Tonsillitis caused by susceptible strains of the designated microorganisms.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 400MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.